Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-tumor medicine composition

A composition and anti-tumor technology, applied in the direction of anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve problems that have not yet been reported

Inactive Publication Date: 2015-05-20
TIANJIN UNIV
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The combination of these three drugs involved in the present invention has a very strong anti-tumor effect, and the combination of any two drugs has not been reported yet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-tumor medicine composition
  • Anti-tumor medicine composition
  • Anti-tumor medicine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] An anti-tumor pharmaceutical composition comprises the following components by weight: 91 parts of the extract of Rhizoma chinensis and 9 parts of curcumin.

Embodiment 2

[0024] An anti-tumor pharmaceutical composition comprises the following components by weight: 83 parts of the extract of Rhizoma chinensis, and 17 parts of curcumin.

Embodiment 3

[0026] An anti-tumor pharmaceutical composition comprises the following components by weight: 71 parts of the extract of Rhizoma chinensis and 29 parts of curcumin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-tumor medicine composition. The medicine composition comprises the following components in parts by weight: 71-91 parts of rhizoma paridis extract and 9-29 parts of curcumin. The composition can be used for remarkably inhibiting growth of LA795 and other lung cancer cell lines and HepG2 and other liver cancer cell lines with IC50 respectively being lower than 20mug / mL; and tests on tumor-bearing mouse models with lung adenocarcinoma, H22 lung cancer, S180 sarcoma and ehrlich ascites tumor indicate that the tumor inhibition rate of the medicine composition is over 50 percent. The medicine composition can be used for increasing the spleen index and thymus index of tumor-bearing mice and improving the living quality of the tumor-bearing mice in comparison with single medicine administration, has high anti-tumor activity, and has a good preventing and treating effect for tumor occurrence.

Description

technical field [0001] The present invention relates to an anti-tumor pharmaceutical composition, in particular to an anti-tumor pharmaceutical composition. Background technique [0002] Cancer is a global public health problem, has become the number one killer in many countries, and will become the disease with the highest morbidity and mortality in the next few decades. The prevention and treatment of cancer has always been a hot topic of research by experts and scholars. Drug therapy is one of the three major therapies for cancer treatment. It began in the 1940s. Compared with surgical treatment and radiation therapy, drug therapy has a much shorter history. However, after decades of development, countries around the world have invented and The total number of anti-tumor drugs approved for use has hundreds of kinds, and the total number of various anti-cancer drug preparations prepared with these raw materials is about 1200-1400 kinds. These drugs are mainly chemotherapy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61P35/00A61K31/12A61K31/4166
Inventor 高文远范亚亚满淑丽刘振李红法高静刘元雪
Owner TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products